A discreet recovery program for Manhattan residents.

Three protections, and together they remove most of what people fear about using insurance for treatment.

1. No prior authorisation for inpatient care

An insurer regulated by New York may not require you or your provider to obtain preauthorisation for medically necessary inpatient substance use disorder services — detoxification, rehabilitation and residential treatment — delivered in-network at an OASAS-certified facility. You do not wait for permission before admission.

2. No utilisation review for the first 28 days

Once admitted, the plan may not conduct concurrent review of medical necessity during the first 28 calendar days, provided the facility notifies the insurer of both the admission and the initial treatment plan within two business days. Coverage may only be denied for that period where the treatment was not medically necessary as measured by the OASAS-designated level-of-care tool — not by the insurer’s own internal criteria.

3. Obligations that run in both directions

The protection is conditional on the provider doing its part: a daily clinical assessment of whether that level of care is still needed, consultation with the insurer at or before the fourteenth day, and a discharge plan handed to both you and the plan. A programme that treats these as paperwork is putting your coverage at risk, which is a fair question to ask before admission.

Where the protection does not reach

Self-funded employer plans are governed by federal law rather than New York insurance law, so these specific rules may not apply — federal parity still does. Out-of-network care sits outside the guarantee. And the rules cover inpatient levels; outpatient and intensive outpatient follow ordinary utilisation review.

Four questions, asked in this order, settle almost everything before you commit to a programme.

Is my plan New York-regulated or self-funded?

Member services will tell you. If the plan is self-funded by an employer, the state protections above may not apply and you fall back on federal parity — still meaningful, but different. This one answer changes the whole picture, and it takes one phone call.

Is the facility OASAS-certified and in-network?

Both conditions are required for the no-prior-authorisation rule. A programme that cannot answer this immediately is not one that works with New York plans often.

Who notifies the insurer, and when?

The two-business-day notice is the facility’s job. Ask who does it and what happens if it slips, because a missed notice is what converts a protected admission into a contested one.

What happens on day 29?

Ordinary concurrent review resumes. A programme should already have documented progress against the level-of-care tool, and should be able to tell you at admission what its plan is for that transition. If nobody has thought about day 29, the plan for day 29 is improvisation.

New York City recorded 2,192 overdose deaths in 2024, down from 3,056 in 2023 — a 28% fall and the largest decline in nearly a decade. Every borough fell, and for the first time since 2018 deaths fell among Black and Latino New Yorkers, though the city’s own reporting is explicit that significant racial and geographic inequities remain.

Why this matters to someone deciding privately

It is evidence that treatment and harm-reduction capacity in this city has improved, not just that risk has moved. For a Manhattan resident that means the local clinical network — the psychiatrist, the therapist, the medication prescriber you step down to — is denser and more competent than it was five years ago. Continuing care near home is a stronger option here than in most of the country.

What it does not mean

It does not mean the supply is safer. The decline is measured in deaths, not in what is circulating, and illicit fentanyl remains the dominant driver in the numbers behind it.

Federal law protects addiction treatment records more strictly than ordinary medical records. 42 CFR Part 2 was written for this category of care and restricts disclosure in ways HIPAA alone does not — which is the part most people in high-visibility roles do not know when they assume private pay is the only discreet route.

What your employer sees

A self-insured employer receives aggregate claims data, not a list of who used behavioural health benefits and for what. The plan administrator is not permitted to hand that list over.

Where the real exposure is

Not the claim. The exposure is calendar-shaped: a month-long absence, an assistant rescheduling, a colleague filling in. This is the argument for choosing the least intensive clinically sufficient level of care rather than defaulting to residential — structured outpatient in New York keeps you in your own life while treatment happens.

What we do about it

No photographs, no social posts, no discharge dates, and a named point of contact rather than a rota. If a licensing body, a board or a counterparty needs to be told something, we would rather help you plan what is said than find out afterwards what was assumed.

These are the questions a clinical programme answers immediately and a broker cannot. Most search results for treatment in this city are lead-generation, not providers.

1. Which ASAM dimension drove your recommendation?

A clinical answer names one of the six dimensions and says what would change it. A sales answer describes the facility.

2. Are you OASAS-certified, and are you in-network with my plan?

Both matter for the protections above, and both are yes-or-no.

3. Who performs the assessment, and do they carry an admissions target?

The honest answer is usually given when the question is asked directly.

4. What is the plan for continuing care in New York?

Named clinicians near home, a scheduled handover, and a defined action for a bad week. Not “we’ll stay in touch”.

5. What would make you tell me I do not need you?

Every real programme has an answer. A programme that fits everyone has decided nothing about what it does.